We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+16.11%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$42.7B
AUM Growth
+$3.67B
(+9.4%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
16.5%
Holding
2,714
New
351
Increased
1,025
Reduced
1,076
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$367M |
| 2 |
Johnson & Johnson
JNJ
|
+$294M |
| 3 |
Fortinet
FTNT
|
+$260M |
| 4 |
General Mills
GIS
|
+$220M |
| 5 |
Rivian
RIVN
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$485M |
| 2 |
Tesla
TSLA
|
+$476M |
| 3 |
Advanced Micro Devices
AMD
|
+$417M |
| 4 |
Coca-Cola
KO
|
+$344M |
| 5 |
Pfizer
PFE
|
+$300M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.54% |
| 2 | Consumer Discretionary | 12.61% |
| 3 | Healthcare | 11.89% |
| 4 | Financials | 10.49% |
| 5 | Industrials | 10.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Medifast
MED
$109M
| $679K | ﹤0.01% |
10,100
| – | – |
|
1802
Jazz Pharmaceuticals
JAZZ
$15.9B
| $677K | ﹤0.01% |
5,500
-40,900
| -88% | -$5.1M |
|
|
HUT
1803
Hut 8
HUT
$12.1B
| $675K | ﹤0.01% |
+50,620
| New | +$540K |
|
1804
Bioventus
BVS
$892M
| $674K | ﹤0.01% |
127,932
+78,400
| +158% | +$310K |
|
1805
Cathay General Bancorp
CATY
$4.22B
| $673K | ﹤0.01% |
15,100
-17,700
| -54% | -$663K |
|
1806
KNOT Offshore Partners
KNOP
$372M
| $671K | ﹤0.01% |
+116,500
| New | +$680K |
|
1807
Mattel
MAT
$4.38B
| $668K | ﹤0.01% |
+35,400
| New | +$689K |
|
1808
South Plains Financial
SPFI
$845M
| $666K | ﹤0.01% |
23,000
-2,600
| -10% | -$70.7K |
|
1809
Globalstar
GSAT
$10.7B
| $657K | ﹤0.01% |
22,567
-586
| -3% | -$12.9K |
|
|
GPGI
1810
GPGI Inc
GPGI
$3.83B
| $656K | ﹤0.01% |
146,286
-48,040
| -25% | -$224K |
|
|
BFS
1811
Saul Centers
BFS
$836M
| $656K | ﹤0.01% |
16,700
+10,800
| +183% | +$396K |
|
1812
Wipro
WIT
$19.6B
| $656K | ﹤0.01% |
235,400
+30,200
| +15% | +$73.3K |
|
1813
Oramed Pharmaceuticals
ORMP
$167M
| $655K | ﹤0.01% |
283,600
+118,000
| +71% | +$252K |
|
1814
IBM
IBM
$211B
| $654K | ﹤0.01% |
4,000
-553,400
| -99% | -$83.6M |
|
1815
Rayonier
RYN
$6.55B
| $651K | ﹤0.01% |
+21,493
| New | +$575K |
|
1816
Park National Corp
PRK
$3.76B
| $651K | ﹤0.01% |
4,900
-6,400
| -57% | -$711K |
|
1817
Lincoln Educational Services
LINC
$1.33B
| $646K | ﹤0.01% |
64,300
+15,000
| +30% | +$137K |
|
1818
Innovative Industrial Properties
IIPR
$1.71B
| $645K | ﹤0.01% |
6,400
+100
| +2% | +$8.2K |
|
|
SUPV
1819
Grupo Supervielle
SUPV
$828M
| $645K | ﹤0.01% |
158,900
+136,400
| +606% | +$372K |
|
1820
Alerus Financial
ALRS
$831M
| $645K | ﹤0.01% |
28,800
-1,400
| -5% | -$26.4K |
|
1821
Mitek Systems
MITK
$754M
| $644K | ﹤0.01% |
49,400
+1,600
| +3% | +$17.8K |
|
1822
BioAtla
BCAB
$5.46M
| $642K | ﹤0.01% |
5,218
+84
| +2% | +$7.28K |
|
1823
Arcus Biosciences
RCUS
$3.55B
| $642K | ﹤0.01% |
33,600
-2,700
| -7% | -$43.2K |
|
1824
Pultegroup
PHM
$24.1B
| $640K | ﹤0.01% |
+6,200
| New | +$527K |
|
|
RPT
1825
Rithm Property Trust
RPT
$95.8M
| $637K | ﹤0.01% |
20,045
+2,350
| +13% | +$72.3K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, Two Sigma Advisers held 2,714 positions worth $42.7B, up 9.4% from $39B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Two Sigma Advisers withdrew a net $1.56B in Q4 2023, closing 234 positions and reducing 1,076 holdings. Its most notable exit was Palo Alto Networks, an estimated $281M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Two Sigma Advisers opened a new position in Block Inc worth $238M.
- Two Sigma Advisers's largest Q4 2023 buy was Block Inc: 3,076,207 shares worth $238M.
- Two Sigma Advisers added most to Merck in Q4 2023, an estimated $367M increase.
- Two Sigma Advisers's biggest Q4 2023 reduction was Nike, cutting an estimated $485M.
- Two Sigma Advisers fully exited Palo Alto Networks in Q4 2023, selling an estimated $281M.
- Two Sigma Advisers's ten largest holdings make up 16% of its $42.7B portfolio in Q4 2023.
- Two Sigma Advisers opened 351 new positions and closed 234 in Q4 2023.
- Two Sigma Advisers's portfolio value rose 9.4% quarter-over-quarter to $42.7B.
Based on Two Sigma Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.